Patent Assignment
Reel/Frame 027212/0182
Change of Name
Recorded: 2011-11-10
Pages: 4
Assignor
GENECRAFT, INC.
Executed: 2003-09-17
Assignee
TRUBION PHARMACEUTICALS, INC.
2401 FOURTH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Properties
(4)
Binding Domain-Immunoglobulin Fusion Proteins
Binding Domain-Immunoglobulin Fusion Proteins
Binding Domain-Immunoglobulin Fusion Proteins
Binding Domain-Immunoglobulin Fusion Proteins
Application:
13/039,097 →
Publication:
US 2011/0223164
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025547/0272 →
Merger
Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0652 →
Merger
Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0733 →
Assignment of Assignor's Interest
Nov 10, 2011
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA S.
To: GENECRAFT, INC.
Reel/Frame 027206/0544 →
Assignment of Assignor's Interest
Nov 10, 2011
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA; THOMPSON, PETER A.
To: GENECRAFT, INC.
Reel/Frame 027206/0537 →
Merger
Nov 16, 2011
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 027239/0310 →
Change of Name
Jul 18, 2016
From: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 039382/0985 →
Security Interest
Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest
Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →